How clinical practice is changing the rules: the sunitinib 2/1 schedule in metastatic renal cell carcinoma

Sergio Bracarda, Sylvie Negrier, Jochen Casper, Camillo Porta, Manuela Schmidinger, James Larkin, Marine Gross Goupil, Bernard Escudier

Research output: Contribution to journalReview articlepeer-review

Fingerprint Dive into the research topics of 'How clinical practice is changing the rules: the sunitinib 2/1 schedule in metastatic renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences